Current project Chourmouzios Arampatzis, Eugene P. McFadden, Lampros K. Michalis, Renu Virmani and Patrick W. Serruys
Current Management and
Treatment provides a state of the art review of current knowledge to aid
specialists, general physicians, and cardiologists in training, in the
diagnosis, risk stratification, and management of patients with diverse
presentations of coronary atherosclerosis.
Publications
h-index 24
Citations more than 2500
Original Reports (peer reviewed articles)
- Arampatzis CA, Ampazidis E, Chourmouzi D, Mpoulogianni G, Lemos
PA, Pentousis D, Louridas G, Kontopoulos A, Mpismpos A, Drevelengas A, Sivitanidis
E. Incidence and Predictors of
Graft Occlusion Prior to Discharge after Coronary Artery Bypass Surgery: A Prospective Study Using
Dual-Source 64-Slice Computed Tomography. EuroIntervention Journal in
press
2.
A prospective, randomized trial of
intravascular-ultrasound guided compared to angiography guided stent
implantation in complex coronary lesions: the AVIO trial. Chieffo A, Latib A, Caussin C, Presbitero P, Galli S, Menozzi A,
Varbella F, Mauri F, Valgimigli M, Arampatzis C, Sabate M, Erglis A,
Reimers B, Airoldi F, Laine M, Palop RL, Mikhail G, Maccarthy P, Romeo F,
Colombo A. Am Heart J. 2013 Jan;165(1):65-72.
3.
Quantification of scientific output in
cardiovascular medicine: a perspective based on global data. Rodriguez-Granillo GA, Rodriguez AE, Bruining N, Milei J, Aoki J,
Tsuchida K, Del Valle-Fernández R, Arampatzis
CA, Ong AT, Lemos PA, Francisco Ayala F, Garcia-Garcia HM, Saia F,
Valgimigli M, Regar E, McFadden E, Biondi Zoccai G, Barbenza E, Schoenhagen P,
Serruys PW. EuroIntervention. 2013 Aug 26. doi:pii:
20130130-05. [Epub ahead of print]
4.
Thanopoulos BV,
Giannakoulas
G,
Arampatzis CA.
Percutaneous pulmonary valve implantation in the native right ventricular
outflow tract. Catheter
Cardiovasc Interv.
2012 Feb 15;79(3):427-9
- Lemos
PA, de Feyter PJ, Serruys PW, Saia F, Arampatzis
CA, Disco C, Mercado N, Mainar V, Moris C, van den Bos AA, Berghoefer
G. Fluvastatin
reduces the 4-year cardiac risk in patients with multivessel disease.
Int J Cardiol. 2005 Feb
28;98(3):479-486.
- van
Domburg RT, Lemos PA, Takkenberg JJ, Liu TK, van Herwerden LA, Arampatzis CA, Smits PC, Daemen
J, Venema AC, Serruys PW, Bogers AJ. The
impact of the introduction of drug-eluting stents on the clinical practice
of surgical and percutaneous treatment of coronary artery disease. Eur Heart
J. 2005 Apr;26(7):675-81
- Mollet
NR, Cademartiri F, Krestin GP, McFadden EP, Arampatzis CA, Serruys PW, de Feyter PJ.
Improved diagnostic accuracy with 16-row multi-slice computed tomography
coronary angiography. J Am Coll Cardiol. 2005 Jan 4;45(1):128-32.
- Daemen
J, Lemos P, Aoki J, Arampatzis C,
Hoye A, McFadden E, Serruys P.
Treatment of Coronary Artery Disease in Dialysis Patients with
Sirolimus-eluting Stents: 1-year Clinical Follow-up of a Consecutive
Series of Cases.
J Invasive Cardiol. 2004 Dec;16(12):685-7.
- Arampatzis
CA, Hoye A, Lemos
P, Saia F, Tanabe K, Degertekin M, Sianos G, Smits P, van der Giessen W,
McFadden E, van Domburg R, de Feyter P, Serruys PW. Elective
sirolimus-eluting stent implantation for multivessel disease involving
significant LAD stenosis. One-year clinical outcomes of 99 consecutive
patients - The Rotterdam experience. Catheter Cardio Interventions 2004;
63(1): 57-60
- Arampatzis
CA, Lemos P, Hoye
A, Saia F, Tanabe K, Smits P, van der Giessen W, McFadden E, de Feyter P, Serruys
PW. Elective sirolimus-eluting stent implantation for left main coronary
artery disease-6 month angiographic follow-up and one-year clinical
outcome. Catheter Cardio Interventions 2004; 62(3) 92-96
- Arampatzis
CA, Lemos P,
Tanabe K, Hoye A, Degertekin M, Saia F, Lee C, Ruiter A, Sianos G, Smits
P, van der Giessen W, de Feyter P, van Domburg R, Serruys PW.
Effectiveness of sirolimus-eluting stent implantation for treatment of
left main coronary artery disease. American Journal of Cardiology 2003; 92:327-329
- Arampatzis
CA, Ligthart J,
Schaar J, Nieman K, Serruys PW, de Feyter P. Detection of a coronary vulnerable plaque: a
treatment dilemma. Circulation 2003; 108: e34-35
- Arampatzis
CA, Goedhart D,
Saia F, Lemos P, Serruys PW, de Feyter P. Fluvastatin reduces the impact
of diabetes on long-term outcome after coronary intervention. A LIPS
substudy. American H Journal, 2005 Feb;149(2):329-35.
- Lemos
P, Arampatzis CA, Hoye A, Daemen J, Saia F, van der Giessen W,
McFadden E, Sianos G, Smits P, de Feyter P, Hofma S, van Domburg R,
Serruys PW. Impact of baseline renal function on mortality after
percutaneous coronary intervention with sirolimus-eluting stents or bare
metal stents. Am J Cardiol. 2005 Jan
15;95(2):167-72.
- Lemos
P, Arampatzis CA, Saia F, Hoye A, Degertekin M, Tanabe K, Lee C,
Cummins P, Smits P, McFadden E, Sianos G, de Feyter P, van der Giessen W,
van Domburg R, Serruys PW. Treatment of very small vessels with 2.25mm
diameter sirolimus eluting stents from the RESEARCH registry. Am J Cardiol
2004;93:633-6.
- Degertekin
M, Arampatzis CA, Lemos P, Saia F, Hoye A, Daemen J, Tanabe K, Lee C, Hofma S,
Sianos G, McFadden E, van der Giessen W, Smits P, de Feyter P, van Domburg
R, Serruys PW. Very long sirolimus-eluting stent implantation for de novo
coronary lesions. Am J Cardiol 2004;93:826-9.
- Lemos
P, van Mieghem C, Arampatzis CA, Hoye A, Ong A, McFadden E, Sianos
G, Hofma S, Smits P, van der Giessen W, de Feyter P, van Domburg R,
Serruys PW. Post-Sirolimus eluting stent restenosis treated with repeat
percutaneous intervention: Late angiographic and clinical outcomes. Circulation.
2004 Jun 1;109(21):2500-2. Epub 2004 May 17
- Saia
F, Lemos P, Arampatzis CA, Hoye A, McFadden E, Sianos G, Smits P,
van der Giessen W, de Feyter P, van Domburg R, Serruys PW. Clinical and
angiographic outcomes after over-dilatation of undersized
sirolimus-eluting stents with largely oversized balloons. An observational
study. Catheter Cardiovascular Interventions 2004;61(4) 455-460.
- Saia
F, Lemos P, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Lee C,
Sianos G, Smits P, van der Giessen W, de Feyter P, Serruys PW. Routine
sirolimus-eluting stent implantation for unselected in-stent restenosis:
Insights from The Rapamycin Eluting Stent Evaluated
At Rotterdam Cardiology Hospital (RESEARCH)
registry. Heart 2004; 90 (10): 1183-8.
- Aoki
J, Ong A, Arampatzis CA, Vijaykumar M, Rodriguez Granillo G, Disco C,
Serruys PW. Three year clinical outcome after coronary stenting or
coronary artery bypass grafting in patients with multivessel disease
involving proximal left anterior descending lesions- A subanalysis of the
ARTS trial. Am J Cardiol. 2004 Sep
1;94(5):627-31.
- Hoye
A, Lemos P, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Daemen
J, Smits P, McFadden E, Sianos G, de Feyter P, van der Giessen W, Hofma S,
van Domburg R, Serruys PW. Sirolimus-eluting stent implantation for
lesions with<50% diameter stenosis: implications for plaque
stabilization. Am J Cardiol. 2004 Jul
1;94(1):112-4
- Hoye
A, Lemos P, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Hofma S,
McFadden E, Sianos G, Smits P, van der Giessen W, de Feyter P, van Domburg
R, Serruys PW. Effectiveness of the sirolimus-eluting stent in the
treatment of saphenous vein graft disease. Results of the RESEARCH (The
Rapamycin Eluting Stent Evaluated At Rotterdam
Cardiology Hospital) registry. J
Invasive Cardiol. 2004 May;16(5):230-3.
- Hoye
A, Lemos P, Arampatzis CA, Saia F, Tanabe K, Degertekin M, Hofma S,
McFadden E, Sianos G, Smits P, van der Giessen W, de Feyter P, van Domburg
R, Serruys PW. Effectiveness of the sirolimus-eluting stent in the
treatment of patients with prior history of coronary artery bypass graft
surgery. Coron Artery Dis. 2004
May;15(3):171-5.
- Lemos
P, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen W,
McFadden E, Sianos G, Smits P, Hofma S, de Feyter P, van Domburg R,
Serruys PW. Clinical, Angiographic, and Procedural predictors of
angiographic restenosis after sirolimus-eluting stent implantation in
complex patients – An evaluation from the RESEARCH registry. Circulation
2004;109:1366-70
- de Feyter P, Mollet N, Nieman K, Arampatzis CA, Cademartiri F,
Pattynama P, Serruys PW. Noninvasive visualisation of coronary
atherosclerosis with multislice computed tomography. Cardiovasc Radiat Med. 2004
Jan-Mar;5(1):49-56.
- Lemos
P, Saia F, Ligthart J, Arampatzis CA, Sianos G, Tanabe K, Hoye A,
Degertekin M, Daemen J, McFadden E, Hofma S, Smits P, de Feyter P, van der
Giessen W, van Domburg R, Serruys PW. Coronary restenosis after
sirolimus-eluting stent implantation: Morphological description and
mechanistic analysis from a consecutive series of cases. Circulation 2003;
108:257-260
- Daemen J, Lemos P, Aoki J, Arampatzis C, Hoye A, McFadden E,
Serruys P. Treatment of coronary artery disease
in dialysis patients with sirolimus-eluting stents: 1-year clinical
follow-up of a consecutive series of cases. J Invasive Cardiol. 2004
Dec;16(12):685-7.
- Saia
F, Lemos P, Lee C, Arampatzis CA, Hoye A, Degertekin M, Tanabe K,
Sianos G, Smits P, McFadden E, Hofma S, van der Giessen W, de Feyter P,
van Domburg R, Serruys PW. Sirolimus - eluting stent implantation in ST-
elevation acute myocardial infarction. A clinical and angiographic study.
Circulation 2003; 108:1927-1929
- Degertekin M, Saia F, Lemos PA, Arampatzis
CA, Serruys PW. Sirolimus-eluting stents for the treatment of in-stent
restenosis. Minerva Cardioangiol. 2003
Sep;51(5):475-84
- Lemos
P, de Feyter P, Serruys PW, Saia F, Arampatzis CA, Disco C, Mercado
N, Mainar V, Morís
C, van den Bos A, Berghoefer G. Fluvastatin reduces the 4-year cardiac
risk in patients with multivessel disease. Int J Cardiol. 2005 Feb 28;98(3):479-86.
- Tanabe
K, Hoye A, Lemos PA, Aoki J, Arampatzis CA, Saia F, Lee Ch,
Degertekin M, Sianos G, Smits PC, van der Giessen WJ, de Feyter P, van
Domburg R, Serruys PW. Restenosis rates following bifurcation stenting
with sirolimus-eluting stent for de novo narrowing. Am
J Cardiol. 2004 Jul 1;94(1):115-8.
- Saia
F, Lemos PA, Hoye A, Sianos G, Arampatzis CA, de Feyter PJ, van der
Giessen WJ, Smits PC, van Domburg RT, Serruys PW.
Clinical outcomes for
sirolimus-eluting stent implantation and vascular brachytherapy for the
treatment of in-stent restenosis. Catheter Cardiovasc
Interv. 2004 Jul;62(3):283-8.
- Lemos
P, Serruys PW, van Domburg R, Saia F, Arampatzis CA, Hoye A,
Degertekin M, Tanabe K, Daemen J, Liu T, McFadden E, Sianos G, Hofma S,
Smits P, van der Giessen W, de Feyter P. Unrestricted utilization of
sirolimus-eluting stents compared to conventional bare stent implantation
in the “real world”. A study of 1200 patients from The Rapamycin Eluting
Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.
Circulation 2004; 109:190-5.
- Saia
F, Lemos P, Sianos G, Degertekin M, Lee C, Arampatzis CA, Hoye A,
Tanabe K, Regar E, van der Giessen W, Smits P, de Feyter P, Ligthart J,
van Domburg R, Serruys PW. Effectiveness of sirolimus-eluting stent
implantation for recurrent in-stent restenosis after brachytherapy.
American Journal of Cardiology 2003; 92:200-203
- Lemos
P, Lee C, Degertekin M, Saia F, Tanabe K, Arampatzis CA, Hoye A,
van Drunen M, Sianos G, Smits P, de Feyter P, van der Giessen W, van
Domburg R, Serruys PW. Early outcome after sirolimus-eluting stent
implantation in patients with acute coronary syndromes-Insights from The
Rapamycin Eluting Stent Evaluated At Rotterdam
Cardiology Hospital (RESEARCH) registry. J Am Coll Cardiol
2003;41:2093-2099
- Saia
F, de Feyter P, Serruys PW, Lemos P, Arampatzis CA, Hendrickx G,
Delarche N, Goedhart D, Lesaffre E, Branzi A, for the Lescol Intervention
Prevention Study (LIPS) Investigators. Effect of fluvastatin on long-term
outcome after coronary revascularization with stent implantation. Am
J Cardiol. 2004 Jan 1;93(1):92-5
- Lemos P, Saia F, Hofma S, Daemen J, Ong A, Arampatzis CA,
Hoye A, McFadden E, Sianos G, Smits P, van der Giessen W, de Feyter P, van
Domburg R, Serruys PW. Short- and Long-Term Clinical Benefit of
Sirolimus-Eluting Stents Compared to Conventional Bare Stents for Patients
With Acute Myocardial Infarction JACC 2004;43:704-8
- Hoye
A, Tanabe K, Lemos P, Aoki J, Saia F, Arampatzis CA, Degertekin M,
Hofma S, Sianos G, McFadden E, van der Giessen W, Smits P, de Feyter P,
van Domburg, Serruys PW. Low restenosis following the use of
sirolimus-eluting stents in the treatment of chronic total
occlusions. J
Am Coll Cardiol. 2004 Jun 2;43(11):1954-8
- de
Feyter P, Serruys PW, Nieman K, Mollet N, Cademartiri F, van Geuns RJ,
Slager C, van der Steen A.F.W, Krams R, Schaar J, Wielopolski P, Pattynama
P.M.T, Arampatzis CA, van der Lugt A, Regar E, Ligthart J,
Smits P. Imaging of coronary atherosclerosis and identification of the
vulnerable plaque. Netherlands
Heart Journal, 11;9:347-358
- Lemos
P, Serruys PW, de Feyter P, Mercado N, Goedhart D, Saia F, Arampatzis
CA, Soares P, Ciccone M, Arquati M, Cortellaro M, Rutsch W,
Legrand W. Long term fluvastatin abolishes the hazardous effect of renal
impairment on 4-year atherosclerotic outcomes - A LIPS substudy. Am
J Cardiol. 2005 Feb 15;95(4):445-51.
- Regar
E, Lemos PA, Saia F, Degertekin M, Tanabe K, Lee CH, Arampatzis CA,
Hoye A, Sianos G, de Feyter P, van der Giessen WJ, Smits PC, van Domburg
RT, Serruys PW.
Incidence of
thrombotic stent occlusion during the first three months after
sirolimus-eluting stent implantation in 500 consecutive patients. Am
J Cardiol. 2004 May 15;93(10):1271-5.
- Hatzinikolaou
H, Arampatzis CA, Tsevekidis H, Koutsibanis G, Katsaris G, Hatseras
D. Left atrial recordings during AV nodal reentrant tachycardia. Europace
2001, The European Working Groups on cardiac pacing and arrhythmias.
Book
Chapters
- Arampatzis CA, Smits P, van der Giessen W, Geuns R,
Poldermans D, de Feyter P, McFadden
E, Serruys PW. Cell transplantation for myocardial repair. Current
perspectives, clinical applications, and future directions. In Marco J,
Serruys PW, Biamino G, Fajadet J, de Feyter P, Morice MC (Eds): The Paris
course on revascularization. Paris: Europa edition. 2004.
- Arampatzis CA, McFadden E,
Sianos G, Saia F, Smits P, van der Giessen W, de Feyter P, Serruys PW. Non-balloon technology in the DES
era. (Rotablator, Atherectomy, Thrombectomy). In Marco J, Serruys PW,
Biamino G, Fajadet J, de Feyter P, Morice MC (Eds): The Paris course on
revascularization. Paris: Europa edition. 2004.
- J.A. Shaar,
A.F.W. van der Steen, C.A. Arampatzis, R. Krams, C.J.Slager, A.G.
ten Have, S.W. van de Poll, F.J.Gijsen, J.J. Wentzel, P.J de Feyter.
Diagnosis of vulnerable plaques in the cardiac catheterization laboratory.
In Y. Saijo, A.F.W. van der Steen (Eds): Vascular Ultrasound.
Springer-Verlag Tokyo 2003
- C. A. Arampatzis, I. Kanonidis, PW Serruys Immunoallergic syndromes in
interventional cardiology. In Lemos, Martinez,
Ong, Serruys (Eds): Common Clinical Dilemmas in Percutaneous Coronary
Interventions. 2007 Informa UK Ltd
- C. A. Arampatzis, V Voudris Coronary
Anomalies and Fistulae. An overview of important entities. In Lemos,
Schoenhagen and Alexandra Lansky. Diagnostic methods in the
catheterization laboratory: a practical approach for specific clinical
situations. 2010 Informa UK Ltd
Assessment
reports
1. Arampatzis CA. Molecular strategies
for restenosis. Aristotelian University of Thessaloniki, department of medical
informatics.